GelSana Hires Chief Commercial Officer
Medtech Industry Veteran joins GelSana as Chief Commercial Officer
(AURORA, CO) – January 09, 2026 – GelSana Therapeutics, Inc. (“GelSana”), a wound care company developing novel polymer-based dressings to accelerate healing, today announced that Donald Gregg has joined the company as Chief Commercial Officer (CCO). In this new role, Gregg will lead all commercial strategy and execution as GelSana prepares for the launch of its first product, Cleragel™.
Gregg is a transformative commercial leader with more than 25 years’ experience leading high-performing global commercialization organizations. He has led med-tech and technology businesses and launched several products in both start-ups and large multi-national corporations. Most recently, Gregg served as President of Zynex Monitoring Solutions, Inc., where he built and led all functions for the company’s non-invasive patient monitoring portfolio.
